Version 1
: Received: 5 November 2023 / Approved: 8 November 2023 / Online: 8 November 2023 (15:52:54 CET)
Version 2
: Received: 22 December 2023 / Approved: 22 December 2023 / Online: 22 December 2023 (07:53:29 CET)
Ouchida, T., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.
Ouchida, T., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.
Ouchida, T., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.
Ouchida, T., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.
Abstract
The C-X-C motif chemokine receptor-1 (CXCR1) is a rhodopsin-like G-protein-coupled receptor, expressed on the cell surface of immune cells and tumors. CXCR1 interacts with some C-X-C chemokines, such as CXCL6, CXCL7, and CXCL8/interleukin-8, which are produced by various cells. Since CXCR1 is involved in several diseases including tumors and diabetes mellitus, drugs targeting CXCR1 has been developed. Therefore, the development of sensitive monoclonal antibodies (mAbs) for CXCR1 has been desired for the diagnosis and treatment. This study established a novel anti-mouse CXCR1 (mCXCR1) mAb; Cx1Mab-1 (rat IgG1, kappa), using the Cell-Based Immunization and Screening (CBIS) method. Cx1Mab-1 reacted with mCXCR1-overexpressed Chinese hamster ovary-K1 (CHO/mCXCR1) and mCXCR1-overexpressed LN229 glioblastoma (LN229/mCXCR1) in flow cytometry. Cx1Mab-1 demonstrated a high binding affinity for CHO/mCXCR1 and LN229/mCXCR1 with a dissociation constant of 2.6×10-9 M and 2.1×10-8 M, respectively. Furthermore, Cx1Mab-1 could detect mCXCR1 by western blot analysis. These results indicated that Cx1Mab-1 is useful for detecting mCXCR1, and provides a possibility for targeting mCXCR1-expressing cells in vivo experiments.
Medicine and Pharmacology, Oncology and Oncogenics
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
